Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Seminars in Cancer Biology|February 13, 2018
New weapons to penetrate the armor: Novel reagents and assays developed at the NCI RAS Initiative to enable discovery of RAS therapeuticsDominic Esposito, Andrew G Stephen, Thomas J Turbyville, et al.Cold Spring Harbor Perspectives in Medicine|November 5, 2017
Efforts to Develop KRAS InhibitorsMatthew HolderfieldNature Reviews. Cancer|June 25, 2014
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyondMatthew Holderfield, Marian M Deuker, Frank McCormick, et al.Cancer Research|January 5, 2011
Carminomycin I is an apoptosis inducer that targets the Golgi complex in clear cell renal carcinoma cellsGirma M Woldemichael, Thomas J Turbyville, W Marston Linehan, et al.Iscience|February 2, 2022
Recapitulation of cell-like KRAS4b membrane dynamics on complex biomimetic membranesRebika Shrestha, De Chen, Peter Frank, et al.Molecular Cancer Therapeutics|October 18, 2005
The anticancer activity of the fungal metabolite terrecyclic acid A is associated with modulation of multiple cellular stress response pathwaysThomas J Turbyville, E M Kithsiri Wijeratne, Luke Whitesell, et al.Neoplasia (New York, N.Y.)|September 7, 2012
Lack of a functional VHL gene product sensitizes renal cell carcinoma cells to the apoptotic effects of the protein synthesis inhibitor verrucarin AGirma M Woldemichael, Thomas J Turbyville, James R Vasselli, et al.Bioorganic & Medicinal Chemistry|August 15, 2006
A new dihydroxanthenone from a plant-associated strain of the fungus Chaetomium globosum demonstrates anticancer activityE M Kithsiri Wijeratne, Thomas J Turbyville, Anne Fritz, et al.Biomolecules|April 3, 2021
RAS Nanoclusters: Dynamic Signaling Platforms Amenable to Therapeutic InterventionQue N Van, Priyanka Prakash, Rebika Shrestha, et al.Cell|November 23, 2015
K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt SignalingMan-Tzu Wang, Matthew Holderfield, Jacqueline Galeas, et al.Pageof 5